Metabolic studies of methenolone acetate in horses

Methenolone acetate (17 beta-acetoxy-1-methyl-5 alpha-androst-1-en-3-one), a synthetic anabolic steroid, is frequently abused in human sports. It is preferred for its therapeutic efficiency and lower hepatic toxicity compared with its 17 alpha-alkylated analogs. As with other anabolic steroids, methenolone acetate may be used to enhance performance in racehorses. Metabolic studies on methenolone acetate have been reported for humans, whereas little is known about its metabolic fate in horses. This paper describes the investigation of in vitro and in vivo metabolism of methenolone acetate in racehorses. Studies on the in vitro biotransformation of methenolone acetate with horse liver microsomes were carried out. Methenolone (M 1, 1-methyl-5 alpha-androst-1-en-17 beta-ol-3-one) and seven other metabolites (M2-M8) were detected in vitro. They were 1-methyl-5 alpha-androst-1-ene-3,17-dione (M2), 1-methyl-5 alpha-androst-1-er-6-ol-3,17-dione (M3) and two stereoisomers of 1-methylen-5 alpha-androstan-2-ol-3,17-dione (M4 and M5), 1-methyl-5 alpha-androst-1-en-16-ol-3,17-dione (M6) and monohydroxylated 1-methyl-5 alpha-androst-1-en-17-ol-3-one (M7 and M8). After oral administration of Primobolan (c) (80 tablets x 5 mg of methenolone acetate each) to two thoroughbred geldings, the parent steroid ester was not detected in the post-administration urine samples. However, seven metabolites, namely M1, M6-M8, two stereoisomers of M7 (M9 and M 10) and 1-methyl-5 alpha-androst-1-en-17 alpha-ol-3-one (M11), could be detected. The metabolic pathway for methenolone acetate is postulated. This study has shown that metabolite M1 could be targeted for controlling the abuse of methenolone acetate in horses. (c) 2004 Elsevier B.V. All rights reserved.